• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立一个膀胱癌患者尿液蛋白质综合数据库。

Towards a comprehensive database of proteins from the urine of patients with bladder cancer.

作者信息

Rasmussen H H, Orntoft T F, Wolf H, Celis J E

机构信息

Department of Medical Biochemistry, University of Aarhus, Denmark.

出版信息

J Urol. 1996 Jun;155(6):2113-9.

PMID:8618346
Abstract

PURPOSE

To establish a comprehensive two-dimensional database of proteins from the urine of patients with bladder cancer.

MATERIALS AND METHODS

Urines dialized against distilled H2O were freeze-dried and subjected to isoelectrofocusing two-dimensional gel electrophoresis. Coomassie brilliant blue stained dry gels were scanned and analyzed with the PDQUEST software. Proteins were identified by one or more of the following techniques: microsequencing (44 proteins), mass spectrometry, comigration and immunoblotting.

RESULTS

The urine protein database, which includes all the polypeptides detected in the urines of 50 patients, lists 339 proteins (including variants) of which 124 have been identified. Of these, psoriasin, the psoriasis-associated fatty acid binding protein 5, the gelsolin fragments and prostaglandin D2 synthetase have not been previously described.

CONCLUSIONS

The database provides a solid basis for further studies aiming at identifying tumor markers in the urine that may serve as prognostic factors in bladder cancer.

摘要

目的

建立膀胱癌患者尿液蛋白质的全面二维数据库。

材料与方法

用蒸馏水透析后的尿液冻干,进行等电聚焦二维凝胶电泳。用考马斯亮蓝染色的干凝胶进行扫描并用PDQUEST软件分析。通过以下一种或多种技术鉴定蛋白质:微量测序(44种蛋白质)、质谱分析、共迁移和免疫印迹。

结果

尿液蛋白质数据库包含在50名患者尿液中检测到的所有多肽,列出了339种蛋白质(包括变体),其中124种已被鉴定。其中,银屑素、银屑病相关脂肪酸结合蛋白5、凝溶胶蛋白片段和前列腺素D2合成酶此前尚未见报道。

结论

该数据库为进一步研究旨在鉴定尿液中可能作为膀胱癌预后因素的肿瘤标志物提供了坚实基础。

相似文献

1
Towards a comprehensive database of proteins from the urine of patients with bladder cancer.建立一个膀胱癌患者尿液蛋白质综合数据库。
J Urol. 1996 Jun;155(6):2113-9.
2
Bladder squamous cell carcinomas express psoriasin and externalize it to the urine.膀胱鳞状细胞癌表达银屑素并将其分泌到尿液中。
J Urol. 1996 Jun;155(6):2105-12.
3
Urinary protein profiling by liquid chromatography/tandem mass spectrometry: ADAM28 is overexpressed in bladder transitional cell carcinoma.液相色谱/串联质谱法进行尿蛋白谱分析:ADAM28 在膀胱移行细胞癌中过表达。
Rapid Commun Mass Spectrom. 2011 Oct 15;25(19):2851-62. doi: 10.1002/rcm.5169.
4
Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.核基质蛋白、纤连蛋白、膀胱癌抗原及晨尿细胞学检查在膀胱肿瘤检测中的比较评估
J Urol. 2002 Aug;168(2):465-9.
5
Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation.膀胱鳞状细胞癌的蛋白质组分析:确定其分化程度的标志物
Cancer Res. 1997 Sep 15;57(18):4111-7.
6
A reference map of human nasopharyngeal squamous carcinoma proteome.人类鼻咽鳞状细胞癌蛋白质组参考图谱。
Int J Oncol. 2007 May;30(5):1077-88.
7
Microsequencing of proteins recorded in human two-dimensional gel protein databases.人类二维凝胶蛋白质数据库中记录的蛋白质微测序。
Electrophoresis. 1991 Nov;12(11):873-82. doi: 10.1002/elps.1150121107.
8
Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach.使用二维差异凝胶电泳(2D-DIGE)方法寻找膀胱癌的尿液肿瘤标志物。
J Proteome Res. 2007 Nov;6(11):4440-8. doi: 10.1021/pr070368w. Epub 2007 Sep 29.
9
Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer.尿前胸腺素α作为膀胱癌检测及随访的新型肿瘤标志物。
Urology. 2006 Feb;67(2):294-9. doi: 10.1016/j.urology.2005.08.034.
10
[Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].[尿BTA-TRAK在浅表性移行细胞膀胱癌随访中的应用]
Arch Esp Urol. 2002 Jan-Feb;55(1):41-9.

引用本文的文献

1
Increased expression of Psoriasin is correlated with poor prognosis of bladder transitional cell carcinoma by promoting invasion and proliferation.Psoriasin 的高表达与膀胱癌不良预后相关,可促进肿瘤侵袭和增殖。
Oncol Rep. 2020 Feb;43(2):562-570. doi: 10.3892/or.2019.7445. Epub 2019 Dec 24.
2
Molecular and cellular impact of Psoriasin (S100A7) on the healing of human wounds.牛皮癣素(S100A7)对人类伤口愈合的分子和细胞影响。
Exp Ther Med. 2017 May;13(5):2151-2160. doi: 10.3892/etm.2017.4275. Epub 2017 Mar 28.
3
S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway.
S100A7通过激活p38/MAPK和RAB2A信号通路在口腔鳞状细胞癌中发挥致癌作用。
Cancer Gene Ther. 2016 Nov;23(11):382-391. doi: 10.1038/cgt.2016.43. Epub 2016 Oct 21.
4
A Quantitative Proteomic Analysis of Urine from Gamma-Irradiated Non-Human Primates.γ射线辐照非人灵长类动物尿液的定量蛋白质组学分析
J Proteomics Bioinform. 2016;9(Suppl 10). doi: 10.4172/jpb.S10-005. Epub 2015 Dec 28.
5
Mechanistic attributes of S100A7 (psoriasin) in resistance of anoikis resulting tumor progression in squamous cell carcinoma of the oral cavity.S100A7(牛皮癣素)在口腔鳞状细胞癌中抗失巢凋亡导致肿瘤进展的机制特性。
Cancer Cell Int. 2015 Jul 29;15:74. doi: 10.1186/s12935-015-0226-9. eCollection 2015.
6
Urinary tumor markers could predict survival in bladder carcinoma.尿液肿瘤标志物可预测膀胱癌的生存率。
Indian J Clin Biochem. 2013 Jul;28(3):265-71. doi: 10.1007/s12291-012-0266-z. Epub 2012 Oct 2.
7
Bladder cancer detection and monitoring: assessment of urine- and blood-based marker tests.膀胱癌的检测和监测:尿液和血液标志物检测的评估。
Mol Diagn Ther. 2013 Apr;17(2):71-84. doi: 10.1007/s40291-013-0023-x.
8
One-step sample concentration, purification, and albumin depletion method for urinary proteomics.一步法尿液蛋白质组学样品浓缩、纯化和白蛋白去除方法。
J Proteome Res. 2010 Nov 5;9(11):6082-9. doi: 10.1021/pr100924s. Epub 2010 Oct 15.
9
Sources of Urinary Proteins and their Analysis by Urinary Proteomics for the Detection of Biomarkers of Disease.尿蛋白的来源及其通过尿蛋白质组学分析以检测疾病生物标志物
Proteomics Clin Appl. 2009 Aug 26;3(9):1029-1043. doi: 10.1002/prca.200800243.
10
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics.用于生物标志物发现和疾病诊断的人类尿液蛋白质组的毛细管电泳-质谱分析。
Proteomics Clin Appl. 2008 Jul 10;2(7-8):964. doi: 10.1002/prca.200800024.